Australia markets open in 6 hours 42 minutes

BioRestorative Therapies, Inc. (BRTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.3300+0.0700 (+5.56%)
As of 01:03PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 8.53M
Enterprise value -2.36M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)36.45
Price/book (mrq)0.74
Enterprise value/revenue -35.42
Enterprise value/EBITDA 0.13

Trading information

Stock price history

Beta (5Y monthly) 61.53
52-week change 3-79.38%
S&P500 52-week change 329.31%
52-week high 37.1300
52-week low 31.2000
50-day moving average 31.3505
200-day moving average 31.7327

Share statistics

Avg vol (3-month) 3558.27k
Avg vol (10-day) 3105.97k
Shares outstanding 56.77M
Implied shares outstanding 66.77M
Float 85.49M
% held by insiders 118.80%
% held by institutions 115.23%
Shares short (30 Apr 2024) 4169.56k
Short ratio (30 Apr 2024) 40.13
Short % of float (30 Apr 2024) 43.08%
Short % of shares outstanding (30 Apr 2024) 42.50%
Shares short (prior month 28 Mar 2024) 440.5k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:4000
Last split date 327 Oct 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-16,687.47%

Management effectiveness

Return on assets (ttm)-65.50%
Return on equity (ttm)-105.30%

Income statement

Revenue (ttm)145.8k
Revenue per share (ttm)0.04
Quarterly revenue growth (yoy)421.60%
Gross profit (ttm)N/A
EBITDA -15.06M
Net income avi to common (ttm)-14.42M
Diluted EPS (ttm)-3.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)11.07M
Total cash per share (mrq)1.63
Total debt (mrq)162.32k
Total debt/equity (mrq)1.41%
Current ratio (mrq)10.71
Book value per share (mrq)2.45

Cash flow statement

Operating cash flow (ttm)-6.43M
Levered free cash flow (ttm)-1.08M